BCR and diffuse large B-cell lymphoma: Potential loss-of-function mutations in genes encoding negative regulators of BCR signaling, such as LYN, LAPTM5, PTPN6, GRB2, PRKCD, DGKZ, SLA, and MAP4K1 have collectively been identified in almost 40% of all DLBCL [14].